- Home
- FBRX vs DBI Comparison
FBRX vs DBI Comparison
Compare FBRX & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- DBI
- Stock Information
- Founded
- FBRX N/A
- DBI 1991
- Country
- FBRX United States
- DBI United States
- Employees
- FBRX N/A
- DBI N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- DBI Clothing/Shoe/Accessory Stores
- Sector
- FBRX Health Care
- DBI Consumer Discretionary
- Exchange
- FBRX Nasdaq
- DBI Nasdaq
- Market Cap
- FBRX 154.5M
- DBI 138.7M
- IPO Year
- FBRX N/A
- DBI 1991
- Fundamental
- Price
- FBRX $11.96
- DBI $4.25
- Analyst Decision
- FBRX Strong Buy
- DBI Hold
- Analyst Count
- FBRX 3
- DBI 2
- Target Price
- FBRX $68.00
- DBI $4.50
- AVG Volume (30 Days)
- FBRX 79.4K
- DBI 1.2M
- Earning Date
- FBRX 11-13-2025
- DBI 09-09-2025
- Dividend Yield
- FBRX N/A
- DBI 4.65%
- EPS Growth
- FBRX N/A
- DBI N/A
- EPS
- FBRX N/A
- DBI N/A
- Revenue
- FBRX N/A
- DBI $2,917,437,000.00
- Revenue This Year
- FBRX N/A
- DBI N/A
- Revenue Next Year
- FBRX N/A
- DBI $2.53
- P/E Ratio
- FBRX N/A
- DBI N/A
- Revenue Growth
- FBRX N/A
- DBI N/A
- 52 Week Low
- FBRX $4.11
- DBI $2.18
- 52 Week High
- FBRX $28.68
- DBI $7.46
- Technical
- Relative Strength Index (RSI)
- FBRX 59.36
- DBI 57.57
- Support Level
- FBRX $10.11
- DBI $4.17
- Resistance Level
- FBRX $11.57
- DBI $4.60
- Average True Range (ATR)
- FBRX 0.84
- DBI 0.36
- MACD
- FBRX 0.09
- DBI -0.01
- Stochastic Oscillator
- FBRX 78.22
- DBI 45.42
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.